_id
6915ef77bc934aba376b1f4b
Ticker
RLAY
Name
Relay Therapeutics Inc
Exchange
NASDAQ
Address
399 Binney Street, Cambridge, MA, United States, 02142
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.relaytx.com
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Ka, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and aGal chaperone for Fabry diseases. It also develops RLY-8161, an oncogene driver that belongs to the RAS family of signaling proteins; and RLY-1013, a degrader of estrogen receptor alpha. In addition, the company develops lirafugratinib (RLY-4008), a receptor tyrosine kinase for the treatment of cancer. It has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; Elevar Therapeutics, Inc. for the development and commercialization of RLY-4008; and Pfizer Inc. for the development of RLY-2608 in combination with fulvestrant and atirmociclib. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Last Close
7.79
Volume
1506138
Current Price
8.03
Change
3.0808729139922892
Last Updated
2025-12-03T12:59:06.168Z
Image
data:image/webp;base64,UklGRoICAABXRUJQVlA4IHYCAADwDQCdASpAAEAAPrVQoEsnJKMhphVewOAWiWYAeN9FUxbQtts9wpvGe9AV2X9z/Ebogj7OI6dTOU1Uo0c8jQIX2cMVd38DZUV5j5ZITG6DTzvUeguRgQz3X+gLMB/QigFzlnWNPlkzxiZCN5OeWev3++U3hUfP70AA/viFkF/ib7KFz/51mfX40X//yz/8/v3m2bx46Hm2Lfb/Yn6uwN66EMDLIiY0kX6f9jP1pIEIQlS3KzOeRN4v/yTTPyLukl2dOfxNIpEOOFYXAtjz3BM1xyxaFrMcNNnuhNg1fGcn4TwEsOzrGGox1NSCA9+ibV02d2SaZqqV7Cn7qpC40NLen7JpKRdQHO7Qlgs0T57ymqfR5paX/bEZxYtKgragQnFXvsaFbD82SQ/TiqjsuMw6Ut3jncTF4pULwAJ5oJDxdSgShIpADFndIHAocb9+RYBurOBDQXwBwO5QJ8Ab70PVupkPvAjs5ej4GjR7/eQgKH2GmHGk7nqgQ77HtreiK8pX/bTsuWvON/ykyNKOt4Q37dhRZuBKQG1Hm0eTrK06kRQ7OtHoqCe/aDgz56JdCFI6yFK8h000cjSrFnTgQD+WVJXLW5vXWITVymEOfSa4fujRgpdBtQluUYzEKth/n2GchvGjIKGrhmN29x2uHKO0yedIueqscvhbvxp5EGuh6eOn1YsXyt0t1m8rEd3zFhtexAso65FQSifuwWNB9is3tmwvaAGegIHqZ6LDmfvxnkXE5Cn/bvrIOMwBwS6UxAHBEoI4zDBX2eVBK70iHWRTKm4D2Z80F5WXfcPYsPX1NtKxTKCcDdRRKpDYng6qXZ48UYAAAAA=
Ipo Date
2020-07-16T00:00:00.000Z
Market Cap
1298184576
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.92525
Sentiment Sources
4
Rating
4.3077
Target Price
13.9
Strong Buy
6
Buy
5
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
748000
Gross Profit
-748000
Operating Expenses
79643000
Operating Income
-80391000
Interest Expense
-
Pretax Income
-74149000
Net Income
-74149000
Eps
-0.4301255306531397
Dividends Per Share
-
Shares Outstanding
173322385
Income Tax Expense
-
EBITDA
-73401000
Operating Margin
-
Total Other Income Expense Net
6242000
Cash
91564000
Short Term Investments
504867000
Receivables
-
Inventories
-
Total Current Assets
624014000
Property Plant Equipment
43728000
Total Assets
670000000
Payables
2752000
Short Term Debt
3643000
Long Term Debt
-
Total Liabilities
62291000
Equity
607709000
Depreciation
748000
Change In Working Capital
-3497000
Cash From Operations
-62119000
Capital Expenditures
1000
Cash From Investing
39725000
Cash From Financing
17000
Net Change In Cash
-22377000
PE
-
PB
2.2778753453873484
ROE
-12.201399024862228
ROA
-11.067014925373133
FCF
-62120000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
748000
Quarters > 0 > income Statement > gross Profit
-748000
Quarters > 0 > income Statement > operating Expenses
79643000
Quarters > 0 > income Statement > operating Income
-80391000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-74149000
Quarters > 0 > income Statement > net Income
-74149000
Quarters > 0 > income Statement > eps
-0.4301255306531397
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
172389209
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-73401000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
6242000
Quarters > 0 > balance Sheet > cash
91564000
Quarters > 0 > balance Sheet > short Term Investments
504867000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
624014000
Quarters > 0 > balance Sheet > property Plant Equipment
43728000
Quarters > 0 > balance Sheet > total Assets
670000000
Quarters > 0 > balance Sheet > payables
2752000
Quarters > 0 > balance Sheet > short Term Debt
3643000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
62291000
Quarters > 0 > balance Sheet > equity
607709000
Quarters > 0 > cash Flow > net Income
-74149000
Quarters > 0 > cash Flow > depreciation
748000
Quarters > 0 > cash Flow > change In Working Capital
-3497000
Quarters > 0 > cash Flow > cash From Operations
-62119000
Quarters > 0 > cash Flow > capital Expenditures
1000
Quarters > 0 > cash Flow > cash From Investing
39725000
Quarters > 0 > cash Flow > cash From Financing
17000
Quarters > 0 > cash Flow > net Change In Cash
-22377000
Quarters > 0 > ratios > PE
-0.4301255306531397
Quarters > 0 > ratios > PB
2.2778753453873484
Quarters > 0 > ratios > ROE
-12.201399024862228
Quarters > 0 > ratios > ROA
-11.067014925373133
Quarters > 0 > ratios > FCF
-62120000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
677000
Quarters > 1 > income Statement > cost Of Revenue
1002000
Quarters > 1 > income Statement > gross Profit
677000
Quarters > 1 > income Statement > operating Expenses
77524000
Quarters > 1 > income Statement > operating Income
-76847000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-70375000
Quarters > 1 > income Statement > net Income
-70375000
Quarters > 1 > income Statement > eps
-0.41091381966790547
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
171264622
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-75845000
Quarters > 1 > income Statement > operating Margin
-11351.107828655835
Quarters > 1 > income Statement > total Other Income Expense Net
6472000
Quarters > 1 > balance Sheet > cash
113941000
Quarters > 1 > balance Sheet > short Term Investments
542834000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
680392000
Quarters > 1 > balance Sheet > property Plant Equipment
46191000
Quarters > 1 > balance Sheet > total Assets
728841000
Quarters > 1 > balance Sheet > payables
5176000
Quarters > 1 > balance Sheet > short Term Debt
3525000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
63183000
Quarters > 1 > balance Sheet > equity
665658000
Quarters > 1 > cash Flow > net Income
-70375000
Quarters > 1 > cash Flow > depreciation
-392000
Quarters > 1 > cash Flow > change In Working Capital
-1909000
Quarters > 1 > cash Flow > cash From Operations
-55261000
Quarters > 1 > cash Flow > capital Expenditures
26000
Quarters > 1 > cash Flow > cash From Investing
75146000
Quarters > 1 > cash Flow > cash From Financing
653000
Quarters > 1 > cash Flow > net Change In Cash
20538000
Quarters > 1 > ratios > PE
-0.41091381966790547
Quarters > 1 > ratios > PB
2.066008242460843
Quarters > 1 > ratios > ROE
-10.572245807907365
Quarters > 1 > ratios > ROA
-9.655741101282722
Quarters > 1 > ratios > FCF
-55287000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-81.66469719350074
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
7679000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
7679000
Quarters > 2 > income Statement > operating Expenses
92548000
Quarters > 2 > income Statement > operating Income
-84869000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-77065000
Quarters > 2 > income Statement > net Income
-77065000
Quarters > 2 > income Statement > eps
-0.4553776711188774
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
169233155
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-83661000
Quarters > 2 > income Statement > operating Margin
-1105.2090115900507
Quarters > 2 > income Statement > total Other Income Expense Net
7804000
Quarters > 2 > balance Sheet > cash
93542000
Quarters > 2 > balance Sheet > short Term Investments
616813000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
739659000
Quarters > 2 > balance Sheet > property Plant Equipment
55284000
Quarters > 2 > balance Sheet > total Assets
799362000
Quarters > 2 > balance Sheet > payables
8450000
Quarters > 2 > balance Sheet > short Term Debt
5930000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
78281000
Quarters > 2 > balance Sheet > equity
721081000
Quarters > 2 > cash Flow > net Income
-77065000
Quarters > 2 > cash Flow > depreciation
-389000
Quarters > 2 > cash Flow > change In Working Capital
-15081000
Quarters > 2 > cash Flow > cash From Operations
-73210000
Quarters > 2 > cash Flow > capital Expenditures
384000
Quarters > 2 > cash Flow > cash From Investing
42465000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-30745000
Quarters > 2 > ratios > PE
-0.4553776711188774
Quarters > 2 > ratios > PB
1.88459026745955
Quarters > 2 > ratios > ROE
-10.687426239215844
Quarters > 2 > ratios > ROA
-9.640813548805172
Quarters > 2 > ratios > FCF
-73594000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-9.583799973954942
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
1334000
Quarters > 3 > income Statement > gross Profit
-7244000
Quarters > 3 > income Statement > operating Expenses
84979000
Quarters > 3 > income Statement > operating Income
-84979000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-76004000
Quarters > 3 > income Statement > net Income
-76004000
Quarters > 3 > income Statement > eps
-0.4541956472311578
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
167337579
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-83645000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
8975000
Quarters > 3 > balance Sheet > cash
124287000
Quarters > 3 > balance Sheet > short Term Investments
657036000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
809204000
Quarters > 3 > balance Sheet > property Plant Equipment
57673000
Quarters > 3 > balance Sheet > total Assets
871296000
Quarters > 3 > balance Sheet > payables
14097000
Quarters > 3 > balance Sheet > short Term Debt
5727000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
93504000
Quarters > 3 > balance Sheet > equity
777792000
Quarters > 3 > cash Flow > net Income
-76004000
Quarters > 3 > cash Flow > depreciation
1334000
Quarters > 3 > cash Flow > change In Working Capital
1449000
Quarters > 3 > cash Flow > cash From Operations
-57868000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
28998000
Quarters > 3 > cash Flow > cash From Financing
800000
Quarters > 3 > cash Flow > net Change In Cash
-28070000
Quarters > 3 > ratios > PE
-0.4541956472311578
Quarters > 3 > ratios > PB
1.7276093857612318
Quarters > 3 > ratios > ROE
-9.771764173455114
Quarters > 3 > ratios > ROA
-8.723097546643162
Quarters > 3 > ratios > FCF
-57868000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
43
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
10007000
Annuals > 0 > income Statement > cost Of Revenue
5464000
Annuals > 0 > income Statement > gross Profit
10007000
Annuals > 0 > income Statement > operating Expenses
382475000
Annuals > 0 > income Statement > operating Income
-372468000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-337708000
Annuals > 0 > income Statement > net Income
-337708000
Annuals > 0 > income Statement > eps
-2.3637789340476085
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
142867844
Annuals > 0 > income Statement > income Tax Expense
-337708000
Annuals > 0 > income Statement > EBITDA
-380210000
Annuals > 0 > income Statement > operating Margin
-3722.0745478165286
Annuals > 0 > income Statement > total Other Income Expense Net
34760000
Annuals > 0 > balance Sheet > cash
124287000
Annuals > 0 > balance Sheet > short Term Investments
657036000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
809204000
Annuals > 0 > balance Sheet > property Plant Equipment
57673000
Annuals > 0 > balance Sheet > total Assets
871296000
Annuals > 0 > balance Sheet > payables
14097000
Annuals > 0 > balance Sheet > short Term Debt
5727000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
93504000
Annuals > 0 > balance Sheet > equity
777792000
Annuals > 0 > cash Flow > net Income
-337708000
Annuals > 0 > cash Flow > depreciation
5464000
Annuals > 0 > cash Flow > change In Working Capital
14620000
Annuals > 0 > cash Flow > cash From Operations
-249107000
Annuals > 0 > cash Flow > capital Expenditures
2018000
Annuals > 0 > cash Flow > cash From Investing
-41083000
Annuals > 0 > cash Flow > cash From Financing
270153000
Annuals > 0 > cash Flow > net Change In Cash
-20037000
Annuals > 0 > ratios > PE
-2.3637789340476085
Annuals > 0 > ratios > PB
1.3757921803772732
Annuals > 0 > ratios > ROE
-43.41880605611783
Annuals > 0 > ratios > ROA
-38.75927354194212
Annuals > 0 > ratios > FCF
-251125000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-25.09493354651744
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
25546000
Annuals > 1 > income Statement > cost Of Revenue
5269000
Annuals > 1 > income Statement > gross Profit
25546000
Annuals > 1 > income Statement > operating Expenses
398546000
Annuals > 1 > income Statement > operating Income
-373000000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-341973000
Annuals > 1 > income Statement > net Income
-341973000
Annuals > 1 > income Statement > eps
-2.7898734641094864
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
122576527
Annuals > 1 > income Statement > income Tax Expense
-37467000
Annuals > 1 > income Statement > EBITDA
-374153000
Annuals > 1 > income Statement > operating Margin
-1460.1111720034448
Annuals > 1 > income Statement > total Other Income Expense Net
31027000
Annuals > 1 > balance Sheet > cash
143736000
Annuals > 1 > balance Sheet > short Term Investments
606350000
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
770103000
Annuals > 1 > balance Sheet > property Plant Equipment
68870000
Annuals > 1 > balance Sheet > total Assets
843980000
Annuals > 1 > balance Sheet > payables
9211000
Annuals > 1 > balance Sheet > short Term Debt
4964000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
91977000
Annuals > 1 > balance Sheet > equity
752003000
Annuals > 1 > cash Flow > net Income
-341973000
Annuals > 1 > cash Flow > depreciation
5269000
Annuals > 1 > cash Flow > change In Working Capital
-32458000
Annuals > 1 > cash Flow > cash From Operations
-300316000
Annuals > 1 > cash Flow > capital Expenditures
4126000
Annuals > 1 > cash Flow > cash From Investing
257634000
Annuals > 1 > cash Flow > cash From Financing
34753000
Annuals > 1 > cash Flow > net Change In Cash
-7929000
Annuals > 1 > ratios > PE
-2.7898734641094864
Annuals > 1 > ratios > PB
1.2208703784825325
Annuals > 1 > ratios > ROE
-45.474951562693235
Annuals > 1 > ratios > ROA
-40.51908813005048
Annuals > 1 > ratios > FCF
-304442000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-11.917403898849136
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1381000
Annuals > 2 > income Statement > cost Of Revenue
4130000
Annuals > 2 > income Statement > gross Profit
1381000
Annuals > 2 > income Statement > operating Expenses
300656000
Annuals > 2 > income Statement > operating Income
-299275000
Annuals > 2 > income Statement > interest Expense
8766000
Annuals > 2 > income Statement > pretax Income
-290509000
Annuals > 2 > income Statement > net Income
-290509000
Annuals > 2 > income Statement > eps
-2.588430013916501
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
112233670
Annuals > 2 > income Statement > income Tax Expense
-36250000
Annuals > 2 > income Statement > EBITDA
-306822000
Annuals > 2 > income Statement > operating Margin
-21670.890658942797
Annuals > 2 > income Statement > total Other Income Expense Net
8766000
Annuals > 2 > balance Sheet > cash
998917000
Annuals > 2 > balance Sheet > short Term Investments
847123000
Annuals > 2 > balance Sheet > receivables
5219000
Annuals > 2 > balance Sheet > inventories
12110000
Annuals > 2 > balance Sheet > total Current Assets
1019505000
Annuals > 2 > balance Sheet > property Plant Equipment
75388000
Annuals > 2 > balance Sheet > total Assets
1099771000
Annuals > 2 > balance Sheet > payables
10578000
Annuals > 2 > balance Sheet > short Term Debt
4276000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
149553000
Annuals > 2 > balance Sheet > equity
950218000
Annuals > 2 > cash Flow > net Income
-290509000
Annuals > 2 > cash Flow > depreciation
4130000
Annuals > 2 > cash Flow > change In Working Capital
11246000
Annuals > 2 > cash Flow > cash From Operations
-229490000
Annuals > 2 > cash Flow > capital Expenditures
9062000
Annuals > 2 > cash Flow > cash From Investing
-188745000
Annuals > 2 > cash Flow > cash From Financing
289910000
Annuals > 2 > cash Flow > net Change In Cash
-128325000
Annuals > 2 > ratios > PE
-2.588430013916501
Annuals > 2 > ratios > PB
0.8846708737363427
Annuals > 2 > ratios > ROE
-30.572879065645985
Annuals > 2 > ratios > ROA
-26.415408298636716
Annuals > 2 > ratios > FCF
-238552000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-172.73859522085445
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3029000
Annuals > 3 > income Statement > cost Of Revenue
3925000
Annuals > 3 > income Statement > gross Profit
3029000
Annuals > 3 > income Statement > operating Expenses
367727000
Annuals > 3 > income Statement > operating Income
-364698000
Annuals > 3 > income Statement > interest Expense
826000
Annuals > 3 > income Statement > pretax Income
-363872000
Annuals > 3 > income Statement > net Income
-363872000
Annuals > 3 > income Statement > eps
-3.824727232815334
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
95136719
Annuals > 3 > income Statement > income Tax Expense
132936000
Annuals > 3 > income Statement > EBITDA
-223082000
Annuals > 3 > income Statement > operating Margin
-12040.211290855068
Annuals > 3 > income Statement > total Other Income Expense Net
826000
Annuals > 3 > balance Sheet > cash
280119000
Annuals > 3 > balance Sheet > short Term Investments
677954000
Annuals > 3 > balance Sheet > receivables
4940000
Annuals > 3 > balance Sheet > inventories
-682491000
Annuals > 3 > balance Sheet > total Current Assets
976242000
Annuals > 3 > balance Sheet > property Plant Equipment
27323000
Annuals > 3 > balance Sheet > total Assets
1008443000
Annuals > 3 > balance Sheet > payables
8276000
Annuals > 3 > balance Sheet > short Term Debt
1844000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
110635000
Annuals > 3 > balance Sheet > equity
897808000
Annuals > 3 > cash Flow > net Income
-363872000
Annuals > 3 > cash Flow > depreciation
3925000
Annuals > 3 > cash Flow > change In Working Capital
97344000
Annuals > 3 > cash Flow > cash From Operations
-74406000
Annuals > 3 > cash Flow > capital Expenditures
3471000
Annuals > 3 > cash Flow > cash From Investing
-479511000
Annuals > 3 > cash Flow > cash From Financing
388090000
Annuals > 3 > cash Flow > net Change In Cash
-165827000
Annuals > 3 > ratios > PE
-3.824727232815334
Annuals > 3 > ratios > PB
0.7936819735511379
Annuals > 3 > ratios > ROE
-40.528932689394615
Annuals > 3 > ratios > ROA
-36.082554988234335
Annuals > 3 > ratios > FCF
-77877000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-25.71046550016507
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.4301255306531397
Valuation > metrics > PB
2.2778753453873484
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-12.201399024862228
Profitability > metrics > ROA
-11.882585967622521
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.10250136167145789
Risk > metrics > Interest Coverage
-107.47459893048128
Risk > final Score
-370
Risk > verdict
High
Liquidity > metrics > Current Ratio
97.57842064112587
Liquidity > metrics > Quick Ratio
97.57842064112587
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
15
Prev Risks > 0
4
Prev Risks > 1
9
Prev Risks > 2
16
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:06:41.172Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-05
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.43
Earnings History > 0 > eps Estimate
-0.418
Earnings History > 0 > eps Difference
-0.012
Earnings History > 0 > surprise Percent
-2.8708
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.41
Earnings History > 1 > eps Estimate
-0.49
Earnings History > 1 > eps Difference
0.08
Earnings History > 1 > surprise Percent
16.3265
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-06-03
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.4554
Earnings History > 2 > eps Estimate
-0.71
Earnings History > 2 > eps Difference
0.2546
Earnings History > 2 > surprise Percent
35.8592
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.45
Earnings History > 3 > eps Estimate
-0.5481
Earnings History > 3 > eps Difference
0.0981
Earnings History > 3 > surprise Percent
17.8982
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-06
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.63
Earnings History > 4 > eps Estimate
-0.77
Earnings History > 4 > eps Difference
0.14
Earnings History > 4 > surprise Percent
18.1818
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-06
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.69
Earnings History > 5 > eps Estimate
-0.73
Earnings History > 5 > eps Difference
0.04
Earnings History > 5 > surprise Percent
5.4795
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-02
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.62
Earnings History > 6 > eps Estimate
-0.7
Earnings History > 6 > eps Difference
0.08
Earnings History > 6 > surprise Percent
11.4286
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-22
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.67
Earnings History > 7 > eps Estimate
-0.73
Earnings History > 7 > eps Difference
0.06
Earnings History > 7 > surprise Percent
8.2192
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-02
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.54
Earnings History > 8 > eps Estimate
-0.83
Earnings History > 8 > eps Difference
0.29
Earnings History > 8 > surprise Percent
34.9398
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-08
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.81
Earnings History > 9 > eps Estimate
-0.82
Earnings History > 9 > eps Difference
0.01
Earnings History > 9 > surprise Percent
1.2195
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.78
Earnings History > 10 > eps Estimate
-0.69
Earnings History > 10 > eps Difference
-0.09
Earnings History > 10 > surprise Percent
-13.0435
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.56
Earnings History > 11 > eps Estimate
-0.7
Earnings History > 11 > eps Difference
0.14
Earnings History > 11 > surprise Percent
20
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-03
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.76
Earnings History > 12 > eps Estimate
-0.71
Earnings History > 12 > eps Difference
-0.05
Earnings History > 12 > surprise Percent
-7.0423
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-04
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.71
Earnings History > 13 > eps Estimate
-0.63
Earnings History > 13 > eps Difference
-0.08
Earnings History > 13 > surprise Percent
-12.6984
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-05
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.57
Earnings History > 14 > eps Estimate
-0.62
Earnings History > 14 > eps Difference
0.05
Earnings History > 14 > surprise Percent
8.0645
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.62
Earnings History > 15 > eps Estimate
-0.58
Earnings History > 15 > eps Difference
-0.04
Earnings History > 15 > surprise Percent
-6.8966
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.66
Earnings History > 16 > eps Estimate
-0.64
Earnings History > 16 > eps Difference
-0.02
Earnings History > 16 > surprise Percent
-3.125
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-2.1
Earnings History > 17 > eps Estimate
-0.46
Earnings History > 17 > eps Difference
-1.64
Earnings History > 17 > surprise Percent
-356.5217
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.47
Earnings History > 18 > eps Estimate
-0.48
Earnings History > 18 > eps Difference
0.01
Earnings History > 18 > surprise Percent
2.0833
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-25
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.7
Earnings History > 19 > eps Estimate
0.17
Earnings History > 19 > eps Difference
0.53
Earnings History > 19 > surprise Percent
311.7647
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-12
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.51
Earnings History > 20 > eps Estimate
-0.35
Earnings History > 20 > eps Difference
-0.16
Earnings History > 20 > surprise Percent
-45.7143
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-27
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-6.06
Earnings History > 21 > eps Estimate
-0.66
Earnings History > 21 > eps Difference
-5.4
Earnings History > 21 > surprise Percent
-818.1818
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-03
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.39
Earnings History > 22 > eps Estimate
-0.39
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
0
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Ka, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and aGal chaperone for Fabry diseases. It also develops RLY-8161, an oncogene driver that belongs to the RAS family of signaling proteins; and RLY-1013, a degrader of estrogen receptor alpha. In addition, the company develops lirafugratinib (RLY-4008), a receptor tyrosine kinase for the treatment of cancer. It has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; Elevar Therapeutics, Inc. for the development and commercialization of RLY-4008; and Pfizer Inc. for the development of RLY-2608 in combination with fulvestrant and atirmociclib. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARelay Therapeutics (RLAY): Revisiting Valuation After a Sharp Rebound in 2024 - Yahoo Finance
12/15/2025
Relay Therapeutics (RLAY): Revisiting Valuation After a Sharp Rebound in 2024 Yahoo Finance
Read more →Meme Stocks: Is RLAY stock recession proof - July 2025 Outlook & Capital Efficiency Focused Strategies moha.gov.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$13.9
Analyst Picks
Strong Buy
6
Buy
5
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 99.25% of the total shares of Relay Therapeutics Inc
1.
SB INVESTMENT ADVISERS (UK) LTD(16.1851%)
since
2025/06/30
2.
BlackRock Inc(8.0937%)
since
2025/06/30
3.
Point72 Asset Management, L.P.(7.7986%)
since
2025/06/30
4.
COMMODORE CAPITAL LP(7.7431%)
since
2025/06/30
5.
Casdin Capital, LLC(6.6113%)
since
2025/06/30
6.
Vanguard Group Inc(5.4404%)
since
2025/06/30
7.
Bellevue Group AG(4.774%)
since
2025/06/30
8.
TANG CAPITAL MANAGEMENT LLC(4.6795%)
since
2025/06/30
9.
BB Biotech AG Ord(4.2776%)
since
2024/12/31
10.
State Street Corp(3.0177%)
since
2025/06/30
11.
Vanguard Total Stock Mkt Idx Inv(2.999%)
since
2025/07/31
12.
JPMorgan Chase & Co(2.5163%)
since
2025/06/30
13.
Nextech Invest, Ltd.(2.2309%)
since
2025/06/30
14.
Geode Capital Management, LLC(1.8732%)
since
2025/06/30
15.
iShares Russell 2000 ETF(1.8727%)
since
2025/08/31
16.
Kynam Capital Management, LP(1.6745%)
since
2025/06/30
17.
T. Rowe Price Associates, Inc.(1.6681%)
since
2025/06/30
18.
Dimensional Fund Advisors, Inc.(1.6179%)
since
2025/06/30
19.
MPM Oncology Impact Management LP(1.324%)
since
2025/06/30
20.
SPDR® S&P Biotech ETF(1.2858%)
since
2025/08/31
21.
Goldman Sachs Group Inc(1.1224%)
since
2025/06/30
22.
Millennium Management LLC(1.0848%)
since
2025/06/30
23.
Alphabet Inc(0.9099%)
since
2025/06/30
24.
Renaissance Technologies Corp(0.8748%)
since
2025/06/30
25.
Vanguard Institutional Extnd Mkt Idx Tr(0.8322%)
since
2025/07/31
26.
Fidelity Small Cap Index(0.7715%)
since
2025/06/30
27.
US Small-Cap Growth II Equity Comp(0.7265%)
since
2025/06/30
28.
iShares Russell 2000 Value ETF(0.6853%)
since
2025/08/31
29.
BlackRock Advantage Small Cap Core Instl(0.6194%)
since
2025/07/31
30.
iShares Biotechnology ETF(0.4513%)
since
2025/08/31
31.
Fidelity Extended Market Index(0.4228%)
since
2025/07/31
32.
T. Rowe Price Health Sciences(0.418%)
since
2025/07/31
33.
DFA US Micro Cap I(0.3946%)
since
2025/07/31
34.
Schwab US Small-Cap ETF™(0.3729%)
since
2025/08/30
35.
Vanguard Russell 2000 ETF(0.3666%)
since
2025/07/31
36.
T. Rowe Price New Horizons(0.3621%)
since
2025/07/31
37.
Vanguard Strategic Small-Cap Equity Inv(0.3121%)
since
2025/06/30
38.
DFA US Targeted Value I(0.2992%)
since
2025/07/31
39.
State St Russell Sm Cap® Indx SL Cl I(0.2717%)
since
2025/08/31
40.
Dimensional US Targeted Value ETF(0.2672%)
since
2025/08/29
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.43
EPS Estimate
-0.418
EPS Difference
-0.012
Surprise Percent
-2.8708%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.